For instance, the suppressor of cytokine signaling 2 (SOCS2) was identified as a biomarker that predicted the sensitivity of hepatocellular carcinoma (HCC) to radiation therapy by enhancing the ubiquitin-mediated degradation of xCT and facilitating ferroptosis [14]. This evidence concerns the gene SOCS2 and hepatocellular carcinoma.